A New Year Brings a New, More Comfortable Juvederm
Posted in Botox and Fillers on February 8th, 2010 by newseditorAllergan Inc announced FDA approval of Juvederm XC last week, the latest filler in
the U.S. to contain the anesthetic lidocaine, for increased comfort during injection.
During the FDA approval process, a clinical trial was cited where 93 percent of the 72 participants reported a more comfortable procedure with Juvederm XC. “Before the introduction of Juvederm XC, it often took up to 30 minutes for an anesthetic block to take effect.” said Charles Boyd, MD, Boyd Cosmetic Surgical Institute and clinical investigator in a company news release.
The new filler follows in the footsteps of Prevelle Silk, another wrinkle filler containing lidocaine. In 2008 however, when Prevelle Silk was introduced the response from surgeons was lukewarm. “The issue with a hyaluronic acid filler with lidocaine is that it doesn’t work until you actually start injecting patients, and these injections are so quick, by the time the lidocaine takes effect, you’re almost finished” said Dr. Joe Niamtu to Cosmetic Surgery Times.
Traditional pain control methods (numbing cream and dental blocks) are quite effective, so it may take some time for Juvederm XC to gain popularity, even if it does offer a significant improvement in pain control.
The results cited by Allergan sound great and the safety profile is very similar, so it could really take off. We’ll know more as Juvederm XC finds its way to cosmetic surgery practices here in southern California.
our accomplishments and focusing on things we could improve. If time has etched lines, wrinkles and grooves into your face, finding a solution may be near the top of your resolutions.
made possible by recent technological advancements in wrinkle fillers. This breakthrough procedure is a cost effective solution for patients who are concerned about looking tired all the time, and are beginning to see loss of volume in the cheeks and the loosening of the skin.
Local 12 news in Ohio recently aired
The liquid facelift is basically soft tissue augmentation with injectable fillers, but the goal is to achieve results that are similar to surgery. Yet the results are said to be “typically more subtle than surgery.” This topic is getting lots of media attention: Harper’s Bazaar is the latest to pick it up and interview some of the physicians that say they’re doing it.
While people sound plenty optimistic about the economy this week, competition in the job market is still pretty fierce. At our Rancho Cucamonga location, we’ve had more than one patient say they suspect that age, or their appearance has affected their job prospects to some extent.
It’s true – we’re carrying the brand new Botox competitor, Dysport. Dysport is marketed by the pharmaceutical company Medicis, the same company that brings you Restylane and Perlane. We weren’t expecting it until mid-July but it’s available in our office as of today. 

